Next Article in Journal
The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study
Next Article in Special Issue
Targeted Anti-Biofilm Therapy: Dissecting Targets in the Biofilm Life Cycle
Previous Article in Journal
Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
Previous Article in Special Issue
Combatting Antibiotic Resistance Using Supramolecular Assemblies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 15
Issue 10
10.3390/ph15101236
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Carbon Dots for Killing Microorganisms: An Update since 2019

by
Fengming Lin
,
Zihao Wang
and
Fu-Gen Wu
*
State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, 2 Sipailou Road, Nanjing 210096, China
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(10), 1236; https://doi.org/10.3390/ph15101236
Submission received: 29 July 2022 / Revised: 14 September 2022 / Accepted: 20 September 2022 / Published: 8 October 2022
(This article belongs to the Special Issue Recent Advances in Antimicrobial Nanodrugs)
Browse Figures
Review Reports Versions Notes

Abstract

:
Frequent bacterial/fungal infections and occurrence of antibiotic resistance pose increasing threats to the public and thus require the development of new antibacterial/antifungal agents and strategies. Carbon dots (CDs) have been well demonstrated to be promising and potent antimicrobial nanomaterials and serve as potential alternatives to conventional antibiotics. In recent years, great efforts have been made by many researchers to develop new carbon dot-based antimicrobial agents to combat microbial infections. Here, as an update to our previous relevant review (C 2019, 5, 33), we summarize the recent achievements in the utilization of CDs for microbial inactivation. We review four kinds of antimicrobial CDs including nitrogen-doped CDs, metal-containing CDs, antibiotic-conjugated CDs, and photoresponsive CDs in terms of their starting materials, synthetic route, surface functionalization, antimicrobial ability, and the related antimicrobial mechanism if available. In addition, we summarize the emerging applications of CD-related antimicrobial materials in medical and industry fields. Finally, we discuss the existing challenges of antimicrobial CDs and the future research directions that are worth exploring. We believe that this review provides a comprehensive overview of the recent advances in antimicrobial CDs and may inspire the development of new CDs with desirable antimicrobial activities.

Graphical Abstract

1. Introduction

Owing to the long-term use and overuse of antibiotics, pathogens have become resistant to almost all existing traditional antibiotics by mutating or acquiring drug-resistant genes from other organisms. It is urgently necessary to develop novel effective antimicrobial compounds as potent alternatives to the conventional small-molecule antibiotics to address the issue of microbial drug resistance. The great advancement of nanoscience and nanotechnology has offered a new solution for the development of antimicrobial materials. Several types of nanomaterials are known to exhibit antibacterial properties. Particularly, inorganic metal and metal oxide nanoparticles have been intensively investigated for their potential use as antimicrobial agents [1,2]. Although these metal (e.g., Au and Ag) and metal oxide (e.g., Fe2O3, CuO, and ZnO) nanoparticles possess antimicrobial activities, the release of metal ions may cause nonspecific biological toxicity, which urgently requires the development of safer antimicrobial nanomaterials [3,4]. Among the large variety of antimicrobial nanomaterials, carbon dots (CDs) have received ever-increasing attention, mainly due to their easy preparation and functionalization, great water dispersity, and satisfactory biocompatibility. One appealing merit for CDs is that their property and function can be easily manipulated during the synthesis or post-modification stage, which is highly useful for antibacterial applications. CDs are zero-dimensional carbonaceous nanoparticles with sizes no more than 20 nm, also termed “carbonized polymer dots”, “carbon quantum dots”, or “carbon nanodots” [5,6,7,8,9,10,11]. CDs can be prepared from a wide variety of natural materials such as biomass and waste, and a huge array of chemical agents [12,13]. There are two well-known CD preparation strategies: bottom-up strategy and top-down strategy. The synthetic approaches for CDs include hydrothermal/solvothermal reaction, pyrolysis, sonication, microwave irradiation, etc. [12]. The broad applications of CDs in sensing [12,14,15,16], optoelectronics [17], energy [18], catalysis [12,19], and nanomedicine [20,21,22,23,24], have been demonstrated since their discovery in 2004 [25].
Currently, three antimicrobial mechanisms have been reported for CDs, including cell wall/membrane disruption, reactive oxygen species (ROS) generation, and DNA damage [23]. The inhibitory action of CDs on microorganisms depends on the composition, size, shape, and surface chemistry of CDs. It is extremely difficult to explain the antimicrobial mechanisms of CDs without performing careful structural characterizations of the CDs. Specifically, the catalytic activity, the crystallographic structure, the surface state (defect or functionalization), and charge transfer are important factors that contribute to the antimicrobial activity of CDs. However, currently, except for the several studies that mentioned the effect of surface functionalization on the antimicrobial activity of CDs [7,24,26], detailed evaluations of the other factors are still lacking in the current CD-based antimicrobial studies. As a result, more attention should be paid to the investigations of the effect of the other factors on the antimicrobial activity of CDs in the future.
In 2019, we have reviewed the advancements of CDs in sensing and killing microorganisms in terms of their preparation, functionalization, toxicity, and underlying antimicrobial mechanism [16]. Nevertheless, the past three years have witnessed the booming applications of CDs in the antimicrobial field. Hence, an update on this topic is essential to embrace the latest progress in this field. Numerous CDs have been reported for antimicrobial therapy in recent years, and they can be classified into four types including nitrogen-doped CDs, metal-containing CDs, antibiotic-conjugated CDs, and photoresponsive CDs (Scheme 1). We discuss their raw materials, synthetic approaches, modification methods, antimicrobial abilities, and the related antimicrobial mechanisms if available in detail below. Furthermore, we also introduce the advances in the applications of the antimicrobial CDs in industry and medicine. Finally, we discuss the current limitations of antimicrobial CDs and propose some research directions.

2. Antimicrobial CDs

2.1. Nitrogen-Doped CDs

2.1.1. Nitrogen-Doped CDs Derived from Biomass

When we prepared our previous review in 2019, a large number of fluorescent CDs synthesized from different natural sources had been harnessed for microbial imaging, but few CDs derived from biomass had been utilized as antimicrobial agents [16]. Nevertheless, in the last three years, the development of green synthetic methods for fabricating antimicrobial CDs from different natural carbon precursors has attracted considerable interest (Table 1), and such a method is facile, cost-effective, and eco-friendly. CDs prepared from Lawsonia inermis (Henna) [27], oyster mushroom (Pleurotus species) [28], osmanthus leaves [29], tea leaves [29], Ananas comosus waste peels [30], Impatiens balsamina L. stems [31], Aloe vera leaves [32], medicinal turmeric leaves (Curcuma longa) [33], rosemary leaves [34], sugarcane bagasse pulp [35], waste tea extract [36], waste jute caddies [37], Forsythia [38], and Artemisia argyi leaves [39], have been reported to possess antimicrobial activities. It is interesting to find that all these biomass-derived CDs contain the nitrogen element, which might be from the proteins, animo acids, and nucleic acids in biomass. For instance, Wang et al. synthesized CDs (ACDs) from Artemisia argyi leaves through a smoking simulation approach (Figure 1A) [39]. ACDs have spherical morphology with a diameter of 2–5 nm (Figure 1B). ACDs displayed selective antibacterial ability toward Gram-negative bacteria like Escherichia coli (E. coli), ampicillin-resistant E. coli (ARE E. coli), kanamycin-resistant E. coli (KRE E. coli), Pseudomonas aeruginosa (P. aeruginosa), and Proteusbacillus vulgaris (P. vulgaris), but not Gram-positive bacteria such as Staphylococcus aureus (S. aureus) and Bacillus subtilis (B. subtilis) (Figure 1C). ACDs could kill 100% Gram-negative bacteria at 150 μg mL−1. The antibacterial mechanism study demonstrated that ACDs could only disrupt the cell walls of E. coli rather than those of S. aureus, since according to the high magnification images in (d and h), only the E. coli cells showed shrunken and damaged cell structures (Figure 1D). In addition, ACDs could change the secondary structure and thus the activity of cell wall-related enzymes in Gram-negative bacteria. More interestingly, ACDs could strongly prevent the biofilm formation of E. coli. The development of ACDs is of great value for the treatment of infections associated closely with Gram-negative bacteria. Saravanan et al. prepared CDs by one-step hydrothermal treatment of medicinal turmeric leaves (Curcuma longa) [33]. The as-prepared CDs exhibited antibacterial activities toward both Gram-negative bacteria (E. coli and Klebsiella pneumoniae (K. pneumoniae)) and Gram-positive bacteria (S. aureus and Staphylococcus epidermidis (S. epidermidis)) due to their release of ROS. Collectively, these naturally derived CDs from biomass represent potent candidates as new antimicrobial agents to combat antibiotic-resistance of microorganisms.

2.1.2. Nitrogen-Doped CDs Derived from Nitrogen-Containing Compounds

In addition to biomass, nitrogen-doped CDs can also be prepared from nitrogenous compounds such as proteins [40], amino acids [41,42,43,44], natural amines [45,46,47], quaternized compounds [48,49], polyethyleneimine (PEI) [50,51,52,53], diethylenetriamine (DETA) [45,54], 2,2′-(ethylenedioxy)-bis(ethylamine) [55], p-phenylenediamine [56], and m-phenylenediamine [57] for antimicrobial purposes.
Nitrogen-doped CDs have been obtained using protein (protamine sulfate) as the raw material. Zhao et al. reported the simple and fast synthesis of multifunctional blue-emitting protamine sulfate (PS)-based CDs (PS-CDs) by a one-step microwave-mediated approach (Figure 2A) [40]. PS-CDs featured great antibacterial efficacy against S. aureus with a minimum inhibitory concentration (MIC) of 25 μg mL−1 and methicillin-resistant S. aureus (MRSA) with an MIC of 37.5 μg mL−1. Furthermore, PS-CDs displayed high water-dispersity, low cytotoxicity, and excellent blood compatibility. The authors also revealed the antibacterial mechanism of PS-CDs: PS-CDs bound to bacteria by electrostatic interaction, damaged cell membrane, entered the cells, and disrupted the normal survival functions of the bacteria. To conclude, this work employs protein as a raw material to prepare CDs that can be internalized easily by bacteria to realize bactericidal effect.
Several CDs prepared from amino acids such as arginine [41], alanine [42,43], L-tryptophan [58,59], cysteine [43,44], lysine [59], and arginine [59] have been reported to possess antimicrobial activities. Suner et al. synthesized nitrogen-doped arginine CDs (termed Arg CDs) utilizing citric acid as the carbon source and arginine as the amine source by a microwave-mediated approach (Figure 2B) [41]. Arg CDs displayed an MIC of 6.250 mg mL−1 against S. aureus. To enhance the antimicrobial activity of Arg CDs, two nanocomposites, Arg-Ag CDs and Arg-Cu CDs, were synthesized by generating Ag and Cu nanoparticles (NPs) within Arg CDs. Arg-Ag CDs and Arg-Cu CDs exhibited an MIC of 0.062 and 0.625 mg mL−1 against S. aureus, respectively. In addition, Arg-Ag CD possessed 0.125 and 0.312 mg mL−1 minimum bactericidal concentration (MBC) values against S. aureus and E. coli, respectively. Pandey et al. prepared CDs from citric acid and β-alanine through a microwave-mediated method [42]. The as-synthesized CDs repressed the growth of diverse Gram-negative bacteria such as E. coli, Salmonella, Pseudomonas, Agrobacterium, and Pectobacterium species.
Besides proteins and amino acids, other natural amines have been explored as precursors to construct antimicrobial CDs, such as histamine [45], cadaverine [45], putrescine dihydrochloride [45], spermine tetrahydrochloride [45], L-glutathione [46], and spermidine [47]. As an example, Hao et al. prepared positively charged CQDs (PC-CQDs) from citric acid and L-glutathione (Figure 2C) [46]. PC-CQDs exhibited high antibacterial activity against S. aureus, E. coli, P. aeruginosa, and MRSA. PC-CQDs strongly attached to the bacterial cell surfaces due to their small size and the surface groups –NH2 and –NH, entered the cells, and induced the conformational change of DNA and the production of ROS, leading to the rupture of the bacterial cells. It is worth noting that PC-CQDs did not cause detectable drug resistance or hemolysis. No drug resistance was observed in S. aureus, E. coli, and MRSA incubated with PC-CQDs for over 30 days. Moreover, PC-CQDs were deployed for the antibacterial treatment of mixed S. aureus- and E. coli-infected wounds in rats with low in vivo toxicity, showing the same therapeutic effect as the traditional antibiotic levofloxacin hydrochloride.
In addition to natural amines as introduced above, other nitrogen-containing agents have also been chosen to prepare nitrogen-doped CDs as antimicrobial agents, including quaternized compounds [48,49], PEI [50,51,52,53], DETA [45,54], 2,2′-(ethylenedioxy)-bis(ethylamine) [55], p-phenylenediamine [56], m-phenylenediamine [57], etc. Our group prepared quaternized CDs through one-step solvothermal treatment of glycerol and dimethyloctadecyl[3-(trimethoxysilyl)propy]ammonium chloride (Si-QAC) for selective Gram-positive bacterial inactivation (Figure 2D) [48]. The synthesized quaternized CDs could selectively interact with the Gram-positive bacteria due to the distinct surfaces of Gram-positive and Gram-negative bacteria. The quaternized CDs possessed a zeta potential of +33 mV, ensuring their successful electrostatic interaction with negatively charged bacterial cells, while the presence of long alkyl chains in the CDs enabled them to interact with the bacterial cells via hydrophobic interaction. Therefore, the CDs could firmly adhere to (or insert into) the bacterial cell surface which changed the charge balance of the bacterial surface, resulting in the inactivation of Gram-positive bacteria both in vitro and in vivo. At the same time, the CDs featured strong fluorescence emission, which was utilized for fast Gram-type identification. In this way, the CDs may hold the potential for treating Gram-positive bacteria-caused infections. More interestingly, in a later study, we have demonstrated that the CDs showed excellent biofilm penetration capacity due to their small size and could effectively inhibit the biofilm formation and eradicate the formed biofilms [22]. Thus, the CDs represent a highly efficient strategy to combat biofilm-involved infections. In another report, Li et al. fabricated different types of polyamine-modified carbon quantum dots (CQDs) including CQD600, CQD1w, and CQD2.5w, via simple hydrothermal treatment of citric acid and branched PEI (bPEI) with different molecular weights [50]. CQD2.5w possessed higher antibacterial and antibiofilm activities against S. aureus and E. coli than CQD1w and CQD600, since the larger molecular weight of bPEI yielded a larger amount of protonated amines on the surface of the CQDs, giving rise to enhanced electrostatic interaction between CQDs and bacterial cells, and the longer surface corona of the CQDs making their penetration into biofilms easier. Additionally, all the three CQDs had negligible cytotoxicity. However, the reason why longer surface corona of CQDs can give rise to their easier penetration into biofilm was not explained, which requires future investigation. Further, Zhao et al. developed nitrogen-doped CDs (NCQDs) as an antimicrobial nanoagent against Staphylococcus to treat infected wounds [54]. NCQDs were made from D(+)-glucose monohydrate and DETA by a heat fusion method. NCQDs displayed antibacterial activity toward Staphylococcus, especially against MRSA. Transmission electron microscopy (TEM) analysis showed that NCQDs could damage the cell structures of S. aureus and MRSA, but not E. coli. NCQDs exhibited the same therapeutic effect as vancomycin in the treatment of MRSA-infected wounds with negligible toxicity to the main rat organs such as heart, kidney, liver, lung, and spleen.

2.2. Metal-Containing CDs

There are different types of metal-containing CDs that can be used as antimicrobial agents: metal ion-doped CDs [36,60,61,62], metal nanoparticle-decorated CDs [41,60,63,64,65], CD/metal oxide nanocomposites [66,67,68,69,70], and CD/metal sulfide nanocomposites [71]. First, CDs doped with metal ions such as Cu2+ [36] and Ag+ [60] have been explored as antimicrobial materials. Qing et al. reported water-dispersible Cu2+-doped CDs (Cu2+–CDs) for antibacterial application [36]. Cu2+–CDs were prepared by one-step hydrothermal carbonization of cupric acetate monohydrate (Cu(Ac)2•H2O) and waste tea extract. Cu2+–CDs showed an inhibitory effect on S. aureus with an MIC of 0.156 mg/mL. Moreover, Cu2+–CDs possessed low cytotoxicity and appealing biocompatibility. Second, CDs can serve as reducing and stabilizing agents to generate metal nanoparticles on their surface, forming metal nanoparticle-modified CDs for killing microorganisms [41,60,63,64,65]. For instance, antimicrobial silver nanoparticle-decorated CDs (CD-2) were prepared using a two-step method, in which CDs (PEI-CD) were first obtained by hydrothermal treatment of PEI, and Ag+ was then reduced to Ag NPs in the presence of formaldehyde and the resultant Ag NPs were bound onto the surface of PEI-CD to produce CD-2 (Figure 3A) [60]. By inducing membrane disruption and intracellular DNA/protein damage, CD-2 displayed high and broad-spectrum antimicrobial activities against Gram-positive bacteria (S. aureus), Gram-negative bacteria (E. coli, P. aeruginosa, and P. vulgaris), and fungi (S. cerevisiae), with excellent biocompatibility. Third, CDs were integrated with metal oxide to form CD/metal oxide nanocomposites [66,67,68,69,70]. As an example, Gao et al. fabricated CD/ZnO/ZnAl2O4 nanocomposites which possessed an excellent antibacterial property with antibacterial ratios of 97% and 94% against S. aureus and E. coli, respectively [68]. Within the antibacterial concentration range, the nanocomposites were nontoxic to human cells. As shown in Figure 3B, the authors proposed a dual-mode antibacterial mechanism for the nanocomposite. On the one hand, the binding of the CD/ZnO/ZnAl2O4 nanocomposites to the surface of the bacteria blocked the channels of the bacterial nutrient supply from the environment, accelerating apoptosis in the bacteria. On the other hand, the nanocomposites could generate singlet oxygen that damages DNA/RNA, proteins, and phospholipids in the bacterial cells. Also, the presence of CDs in the nanocomposites resulted in strengthened electrostatic interaction between the nanocomposites and the bacteria, and increased singlet oxygen production, which enhanced the bacterial elimination effect of the nanocomposite. Lastly, CD/metal sulfide nanocomposites have been constructed for combating microorganisms. Gao et al. synthesized carbon quantum dots (CQDs) through aldol polymerization reaction using acetone as the carbon source (Figure 3C) [71]. Then CQDs/Ag2S/CS nanocomposites were prepared through an in situ growth method using polyvinylpyrrolidone (PVP) as the crosslinking agent. The CQDs/Ag2S/CS nanocomposites exhibited excellent antibacterial property against E. coli and S. aureus with an MIC of 0.1 mg/mL, and against MRSA with an MIC of 0.25 mg/mL. The CQDs/Ag2S/CS nanocomposites strongly bound to the surface of the bacteria, leading to the destruction of cell wall and cell membrane and inducing the bacterial cell death (Figure 3C). Notably, no drug resistance was observed for the CQDs/Ag2S/CS nanocomposites.

2.3. CDs Derived from Antibacterial Compounds (Including Antibiotics)

Antimicrobial CDs have also been developed by using traditional antibiotics and common antibacterial compounds as the raw materials to trade the old for the new, such as kanamycin sulfate [72], levofloxacin hydrochloride [73,74], quaternary ammonium compounds [22,48,49,75,76], and 2,4-dihydroxybenzoic acid [77]. Luo et al. prepared CDs (termed CDs-Kan) from kanamycin sulfate by a one-step hydrothermal method [72]. CDs-Kan were demonstrated to preserve the main bactericidal functional groups of kanamycin like the amino sugar and amino cyclic alcohol, which ensured their good antibacterial activity. Specifically, CDs-Kan inhibited the growth of E. coli and S. aureus with good biocompatibility. Wu et al. reported cationic levofloxacin-derived CDs (LCDs) with enhanced antibacterial activities and low drug resistance (Figure 4A) [74]. LCDs were synthesized from levofloxacin hydrochloride through a simple one-pot hydrothermal method. With the preservation of the active groups from levofloxacin, LCDs featured notable bactericidal activity against S. aureus and E. coli with an MIC of 0.125 μg/mL, which was lower than that of levofloxacin hydrochloride. It is worth noting that LCDs displayed low drug resistance, good aqueous dispersity, and outstanding biosafety, while retaining the broad-spectrum antibacterial activity of levofloxacin. In addition to S. aureus and E. coli, LCDs could kill other microorganisms including MRSA, Enterococcus faecalis (E. faecalis), S. epidermidis, Listera monocytogenes (L. monocytogenes), P. aeruginosa, and Serratia marcescens. LCDs could enter the bacterial cells via electrostatic interaction between the positively-charged LCDs and the negatively-charged bacteria. Once entering the bacterial cells, LCDs produced ROS to destroy cell membrane and the normal state of bacteria, causing cell death. LCDs were deployed for the treatment of bacteria-infected wounds and pneumonia in mice with enhanced therapeutic efficacy without harming normal tissues as compared to levofloxacin. Zhao et al. fabricated quaternary ammonium carbon quantum dots (QCQD) from 2,3-epoxypropyltrimethylammonium chloride and diallyldimethylammonium chloride via the hydrothermal reaction (Figure 4B) [75]. QCQD displayed admirable bactericidal effect toward Gram-positive bacteria, including S. aureus, MRSA, E. faecalis, L. monocytogenes, and S. epidermidis. QCQD also featured satisfactory biocompatibility as demonstrated by in vivo and in vitro toxicity assays. Thus, QCQD were successfully utilized in the treatment of MRSA-infected pneumonia in mice, prompting the regression of pulmonary inflammation in the mouse lung. As revealed by the quantitative proteomics, the antibacterial ability of QCQD could be attributed to the fact that QCQD might mainly act on ribosomes and upregulate the proteins involved in RNA degradation, causing interference to the protein translation, posttranslational modification, and protein turnover in bacterial cells.
Meanwhile, CDs can be employed as the carriers of existing antibiotics to realize the controlled release of these antibiotics. Saravanan et al. prepared N@CDs by hydrothermal treatment of m-phenylenediamine (Figure 4C) [57]. N@CDs exhibited antibacterial activities against E. coli and S. aureus with an MIC of 1 and 0.75 mg/mL, respectively. Additionally, N@CDs were applied as nanovehicles for sustained time-dependent release of the traditional antibiotic ciprofloxacin in the physiological condition.

2.4. Photoresponsive CDs

2.4.1. Photodynamic Therapy (PDT)

In PDT, photosensitive agents (photosensitizers) are sensitized by light in the presence of oxygen to generate ROS such as free radicals and singlet oxygen [78,79]. The produced ROS can break DNA, inactivate enzymes, and oxidize amino acids, resulting in cell necrosis/apoptosis. PDT represents a promising alternative to antibiotics in killing microorganisms, because of its fascinating advantages such as high spatial controllability, antibiotic resistance independence, and low cumulative toxicity. The photo-generated electrons and holes of CDs that are related with PDT action mechanism entail various catalytic processes [80]. Meanwhile, CDs have a relatively wide visible spectral region. These properties enable CDs to be promising antibacterial photosensitizers. After irradiation with light of a given wavelength, some bare CDs can produce ROS that are capable of inactivating microorganisms, and these CDs can thus serve as potent antimicrobial photosensitizers.
Beyond bare CDs fabricated from mushroom [81], graphite rods [82], and the poloxamer Pluronic F-68 [83], as summarized in our previous review [16], more bare CDs have been reported to possess intrinsic photodynamic characteristics, including graphitic carbon nitride quantum dots (g-CNQDs) [84], red-emitting CDs (R-CDs) [77], CQDs constructed from citric acid and 1,5-diaminonaphthalene by solvothermal reaction [85], nitrogen- and/or sulfur-doped CDs derived from amino acids [43], nitrogen and iodine co-doped CDs (N/I-CD) prepared by hydrothermal treatment of iohexol [86], metal-doped CDs such as zinc-doped CDs [87], copper-doped CDs [88], and terbium-doped CDs [89]. Yadav et al. constructed green-fluorescent g-CNQDs from melamine and ethylene diamine tetraacetic acid (EDTA) sodium salt via a thermal polymerization method [84]. g-CNQDs could effectively produce superoxide and hydroxyl radicals with the irradiation of visible light, eradicating ~99% E. coli and ~90% S. aureus at a concentration of 0.1 mg/mL. Moreover, g-CNQDs featured low cytotoxicity—3.2 mg/mL g-CNQDs were nontoxic to fibroblast cells. Liu et al. synthesized R-CDs through solvothermal treatment of 2,4-dihydroxybenzoic acid (an organic bactericide) and 6-bromo-2-naphthol [77]. R-CDs possessed both intrinsic antibacterial activity and antibacterial photodynamic activity toward multidrug-resistant Acinetobacter baumannii (MRAB). R-CDs could effectively enter bacterial cells and bacterial biofilms with few side effects on animal cells. Therefore, R-CDs were successfully utilized for MRAB biofilm prevention and elimination as well as the treatment of MRAB-induced infected wounds. No microbial drug resistance was observed when using R-CDs to kill MRAB and MRSA. These findings demonstrated that R-CDs represent a potent antibacterial agent for fighting against drug-resistant bacteria. Liu et al. fabricated zinc-doped CDs (Zn-CDs) from citric acid, ethylenediamine, and zinc acetate by a one-step hydrothermal method [87]. Zn-CDs produced ROS under blue light irradiation, showing bactericidal effect toward S. aureus and Streptococcus mutans with negligible animal cell toxicity. Collectively, the different types of CDs mentioned above can act as new types of photosensitizers for photodynamic antibacterial treatment.
Besides being used as photosensitizers, CDs can be integrated with other photosensitizers such as curcumin [90], black phosphorus (BP) nanosheets [91], TiO2 [92,93], and ZnO [68,94,95] to afford photoresponsive nanocomposites. In these photosensitive nanocomposites, CDs play different rols in obtaining improved antimicrobial PDT efficacy, such as being used as drug carriers [90], enhancing the interaction of photosensitizers with microorganisms [91,92], preventing the agglomeration of photosensitizers [92], or increasing the light absorption and suppressing photogenerated electron–hole’s recombination [95]. For instance, Yan et al. developed a nano-PS system using CDs to deliver the traditional photosensitizer curcumin (Cur) for enhanced antibacterial performance [90]. Zhang et al. decorated BP nanosheets with cationic CDs through in situ growth of CDs from chlorhexidine gluconate on the surface of BPs, resulting in the formation of the nanocomposite BPs@CDs (Figure 5A) [91]. Without light irradiation, BPs@CDs exhibited antibacterial ability due to the electrostatic attraction between the bacteria and the CDs on the surface of BPs@CDs. Under 660 nm laser irradiation, BPs@CDs produced singlet oxygen, exhibiting outstanding photodynamic antibacterial capacity. Under 808 nm laser irradiation, BPs@CDs displayed photothermal antibacterial activity. Accordingly, the BPs@CDs exhibited synergistic intrinsic antibacterial activity, antibacterial PDT activity, and antibacterial PTT activity toward both E. coli and S. aureus. In addition, BPs@CDs were degradable with no noticeable cytotoxicity. Owing to their triple-mode antibacterial capability, BPs@CDs were successfully deployed for the treatment of bacteria-associated wounds with shortened wound healing time.
The CD-involved antimicrobial PDT systems have been developed in the forms of different nanocomposites. Hydrophobic carbon quantum dots (hCQDs) with photodynamic property made from the poloxamer Pluronic F-68 [83] were encapsulated in polymers such as polydimethylsiloxane (PDMS) [96,97], polycaprolactone [98], and polyurethane [99], and to construct light-triggered antibacterial nanocomposites in the form of slide [96], nanofiber [98], and film [99]. For example, hCQDs were embedded into the PDMS polymer matrix to generate hydrophobic CQDs/PDMS surface by a swelling-encapsulation-shrink method [96]. The nanocomposite surface exhibited bactericidal activities against S. aureus, E. coli, and K. pneumoniae by producing ROS upon the excitation at 470 nm. More importantly, the nanocomposite surface showed no toxicity towards NIH/3T3 cells.

2.4.2. Photothermal Therapy (PTT)

PTT eliminates microorganisms by hyperthermia generated from photothermal agents when they absorb light. Only one kind of antimicrobial CDs with PTT capacity had been reported when we prepared the previous review. Since 2019, more CDs have been reported for antimicrobial PTT [76,100,101]. Belkahla et al. produced CDs from glucose as the precursor through the alkali-assisted ultrasonic irradiation approach [100]. The generated CDs possessed the heat-producing capability under illumination at 680 or 808 nm and were employed for photothermal treatment of E. coli. Yan et al. constructed a nanosystem termed CDs-Tb-TMPDPA, which consisted of TMPDPA (4-(2,4,6-trimethoxyphenyl)-pyridine-2,6-dicarboxylic acid, a two-photon ligand)-sensitized Tb3+ as a temperature-sensitive module and CDs (prepared by microwave heating of citric acid and formamide) as a photothermal antibacterial component [101]. The CDs were coordinated to Tb3+ that was further linked with TMPDPA through coordination interaction. The authors demonstrated that the nanosystem could be used for temperature detection based on the temperature-dependent fluorescence intensity (I) ratio (I(Tb3+)/I(CDs)) and the fluorescence lifetime of CDs-Tb-TMPDPA. Besides, the authors also realized E. coli growth inhibition by utilizing the photothermal conversion property of CDs in CDs-Tb-TMPDPA via two-photon excitation (660 nm). This work develops a multifunctional probe for dual-mode temperature detection and antibacterial PTT under two-photon excitation.
Moreover, CDs-involved PTT can be integrated with other antimicrobial strategies such as PDT [90,93] and chemodynamic therapy (CDT) [102] to achieve combined antimicrobial therapies. For instance, N, S-doped CDs with strong fluorescence were first prepared from citric acid and thiourea by a one-step hydrothermal route, and was combined with curcumin (Cur) to afford CDs/Cur (Figure 5B) [90]. In CDs/Cur, the ROS yield of Cur could be enhanced through fluorescence resonance energy transfer (FRET), while the high photothermal conversion efficiency of the CDs due to their strong light absorption was preserved. As a result, upon 405 nm visible light and near-infrared light irradiation, CDs/Cur could yield ROS and a moderate temperature increase, which seriously damaged bacterial cell surface, leading to synergistic PDT- and PTT-promoted antibacterial effects against E. coli and S. aureus. Furthermore, CDs/Cur displayed low cytotoxicity and negligible hemolytic activity, which ensured their practical application. In another example, Yan et al. developed a nanocomposite termed FeOCl@PEG@CDs by coating poly(ethylene glycol) (PEG) and CDs on iron oxychloride nanosheets (FeOCl NSs) [102]. The hydroxyl radical (•OH) was generated from H2O2 activation by the redox cycle of ions on FeOCl NSs, and the heat was produced from the CDs upon the irradiation at 808 nm, inducing the death of S. aureus and E. coli. Further, the FeOCl@PEG@CDs were successfully applied in synergistic chemodynamic and photothermal treatment of infected wounds.
As far as we know, because only several CDs have been reported for photo-assisted antimicrobial uses, the lethal route was not carefully investigated. Commonly, researchers just reported that bacteria treated with CDs can produce ROS or heat upon light irradiation which can cause cell wall/membrane damage to kill bacteria. Thus, more studies should be performed in the future to thoroughly investigate the underlying lethal mechanism of CD-based antibacterial phototherapy.

3. Applications of Antimicrobial CDs in Medical and Industry Fields

CDs-involved antimicrobial strategies have been deployed in both medical and industry fields. In the medical field, antimicrobial CDs have been leveraged for coating the surface of orthopedic implant materials [66], delivering drugs [24,57,103,104], and repairing infected bone defects [47]. Moradlou et al. grew a thin film of CDs-incorporated hematite (CQDs@α-Fe2O3) on a titanium substrate to yield Ti/CQDs@α-Fe2O3 [66]. CQDs were prepared from graphite rods via an electrochemical method and used as nano-scaffolds for the growth of CQD@α-Fe2O3 nanoparticles as core@shell nanostructures. The Ti/CQDs@α-Fe2O3 samples exhibited sustainable antibacterial activity against S. aureus but not E. coli, offering a way of using CDs to prepare antimicrobial materials for medical devices. In another work, Geng et al. synthesized positively-charged CQDs (p-CQDs) through microwave reaction of spermidine trihydrochloride, and prepared negatively-charged CQDs (n-CQDs) via microwave reaction of 1,3,6-trinitropyrene (TNP) and sodium sulfite (Figure 6A) [47]. The p-CQDs displayed effective antibacterial activity against multidrug-resistant (MDR) bacteria and could realize the inhibition of biofilm formation, while n-CQDs notably promoted bone regeneration. The nearly neutral p-CQD/WS2 hybrids were first fabricated by depositing p-CQDs on WS2 nanosheets, and then coencapsulated with n-CQDs into the gelatin/methacrylate anhydride (GelMA) hydrogel to obtain p-CQD/WS2/n-CQD/GelMA hydrogel scaffold (Figure 6A). The implantation of p-CQD/WS2/n-CQD/GelMA hydrogel scaffold in an MRSA-infected craniotomy defect model induced almost complete repair of an infected bone defect with the new bone area of 97.0 ± 1.6% at 60 days. This work proposes a CD-based strategy for developing biomaterials with both antibacterial and osteogenic activities for the treatment of infected bone defects.
In the industry field, antimicrobial CDs have been utilized to construct thin-film composite membranes for forward osmosis [105] and nanofiller [106], packaging materials [107,108], and lubricant additives [53]. Mahat et al. developed thin-film composite membranes for forward osmosis by embedding CQDs derived from oil palm biomass into polysulfone-selective layers, which were denoted as CQDs-PSF (PSF: polysulfone) [105]. The authors proved that the addition of CQDs into PSF membranes increased water flux and improved antibacterial performance. In another study, Koulivand et al. constructed antifouling and antibacterial nanofiltration membranes for efficient salt and dye rejection by incorporating nitrogen-doped CDs (NCDs) to polyethersulfone (PES) using a phase inversion technique [106]. The antibacterial NCDs were synthesized via hydrothermal treatment of ammonium citrate dibasic. The obtained membrane exhibited improved pure water flux and enhanced antifouling property. In addition, Kousheh et al. constructed a nanocellulose film with antimicrobial/antioxidant and ultraviolet (UV) protective activities for food packaging by introducing water-dispersible and photoluminescent CDs [107]. The antimicrobial CDs were synthesized from cell-free supernatant of Lactobacillus acidophilus via a hydrothermal method. The as-synthesized CDs were embedded into bacterial nanocellulose (BNC) film due to the hydrogen bonding interaction between CDs and the carboxyl, hydroxyl, and carbonyl groups of BNC, leading to the formation of the CD-BNC film. The CD-BNC film displayed a higher inhibitory activity toward Listeria monocytogenes than E. coli. In addition to antibacterial activity, the introduction of CDs into the BNC film also endowed the CD-BNC film with UV-blocking activity, fluorescence appearance, and improved flexibility. The CD-BNC film could be used to fabricate nanopaper for wrapping of food commodity and fabrication of forgery-proof packaging. In addition to thin-film composite membranes and packaging materials, antimicrobial CDs have been implemented as lubricant additives. Tang et al. fabricated CDs from PEG and PEI through a hydrothermal approach [53]. The MICs of the CDs toward E. coli and S. aureus were 62.5 and 15.56 μg mL−1, respectively. Besides the antibacterial activity, the CDs featured anti-friction property. The addition of 0.2% (wt) CDs reduced the mean friction coefficient and wear volume of water-based lubrication by 59.77% and 57.97%, respectively. This example suggests that CDs with antibacterial and anti-friction functions can be utilized as an advanced lubricating additive, thus broadening the practical application of CDs.

4. Conclusions

As reviewed here, CDs are potent antimicrobial nanomaterials and represent promising alternatives to conventional antibiotics for the treatment of infectious diseases caused by microorganisms. Nevertheless, several challenges still exist. First, the potential antibacterial capability and specificity of CDs are difficult to predict from their raw materials, since it is unknown whether the antibacterial groups of raw materials can be retained or there are newly formed antibacterial structures during the complicated CD formation process. The CDs’ functional and biological characteristics are directly associated with their core and particularly their surface’s functional groups, which are largely dependent on the precursors and synthetic methods. Therefore, the structural analysis of CDs and the clarification of the reaction mechanism of CDs are helpful to better predict the antibacterial activities of CDs. Second, the integration of CDs with other compounds such as antibiotics, metal ions, hydrogels, and photosensitive materials to prepare new composite materials with synergistic antibacterial effect represents an important research direction in this field, which is definitely worth exploring in the future. Third, most antimicrobial CDs possess high MICs, and usually can only kill certain types of bacteria such as Gram-positive bacteria. Thus, it is highly desired to develop CDs with low MICs and broad-spectrum antibacterial ability. Fourth, the current antibacterial research of CDs mainly focuses on the killing of planktonic bacteria. In the future, it is necessary to explore the application potential of CDs in combating bacterial biofilms, eliminating intracellular bacteria, and killing bacteria in tumor. Fifth, despite the extensive investigations on the use of CDs for killing bacteria, few examples have been reported on using CDs to eliminate fungi and viruses which can also cause severe infections, diseases, and even death to humans. Sixth, the reproducible, large-scale, and cost-effective fabrication of CDs still limits the practical antimicrobial applications of CDs. Seventh, studies regarding the interaction of CDs with microbial cells, the distribution of CDs in microbial cells, the antimicrobial mechanisms of CDs, and the possible antimicrobial resistance development of CDs are still lacking, which will benefit the development of CDs with broad-spectrum antimicrobial activities, low MICs, and negligible drug resistance. Finally, although CDs are generally shown to be safe by cytotoxicity assays, the in vivo safety analyses of CDs remain largely unexplored, which is definitely worthy of evaluation in future studies. It is hoped that the current review will further promote the future design of functional CDs and CDs-incorporated advanced materials for combating the microbial infection-caused diseases.

Author Contributions

F.L.: Investigation, Analysis, Writing—original draft & editing. Z.W.: Investigation, Writing—original draft. F.-G.W.: Supervision, Analysis, Writing—original draft & editing. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the Natural Science Foundation of Jiangsu Province (BK20211510) and National Natural Science Foundation of China (32170072).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hoseinnejad, M.; Jafari, S.M.; Katouzian, I. Inorganic and metal nanoparticles and their antimicrobial activity in food packaging applications. Crit. Rev. Microbiol. 2018, 44, 161–181. [Google Scholar] [CrossRef] [PubMed]
  2. Raghunath, A.; Perumal, E. Metal oxide nanoparticles as antimicrobial agents: A promise for the future. Int. J. Antimicrob. Agents 2017, 49, 137–152. [Google Scholar] [CrossRef] [PubMed]
  3. Wang, D.; Lin, Z.; Wang, T.; Yao, Z.; Qin, M.; Zheng, S.; Lu, W. Where does the toxicity of metal oxide nanoparticles come from: The nanoparticles, the ions, or a combination of both? J. Hazard. Mater. 2016, 308, 328–334. [Google Scholar] [CrossRef] [PubMed]
  4. Soenen, S.J.; Parak, W.J.; Rejman, J.; Manshian, B. (Intra)cellular stability of inorganic nanoparticles: Effects on cytotoxicity, particle functionality, and biomedical applications. Chem. Rev. 2015, 115, 2109–2135. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, J.; Li, R.; Yang, B. Carbon dots: A new type of carbon-based nanomaterial with wide applications. ACS Cent. Sci. 2020, 6, 2179–2195. [Google Scholar] [CrossRef] [PubMed]
  6. Wu, H.; Lu, S.; Yang, B. Carbon-dot-enhanced electrocatalytic hydrogen evolution. Acc. Mater. Res. 2022, 3, 319–330. [Google Scholar] [CrossRef]
  7. Wang, B.; Song, H.; Qu, X.; Chang, J.; Yang, B.; Lu, S. Carbon dots as a new class of nanomedicines: Opportunities and challenges. Coord. Chem. Rev. 2021, 442, 214010. [Google Scholar] [CrossRef]
  8. Wang, B.; Lu, S. The light of carbon dots: From mechanism to applications. Matter 2022, 5, 110–149. [Google Scholar] [CrossRef]
  9. Li, B.; Zhao, S.; Li, H.; Wang, Q.; Xiao, J.; Lan, M. Recent advances and prospects of carbon dots in phototherapy. Chem. Eng. J. 2021, 408, 127245. [Google Scholar] [CrossRef]
  10. Ðorđević, L.; Arcudi, F.; Cacioppo, M.; Prato, M. A multifunctional chemical toolbox to engineer carbon dots for biomedical and energy applications. Nat. Nanotechnol. 2022, 17, 112–130. [Google Scholar] [CrossRef]
  11. Xu, Y.; Wang, B.; Zhang, M.; Zhang, J.; Li, Y.; Jia, P.; Zhang, H.; Duan, L.; Li, Y.; Li, Y.; et al. Carbon dots as a potential therapeutic agent for the treatment of cancer related anemia. Adv. Mater. 2022, 34, 2200905. [Google Scholar] [CrossRef]
  12. Dhenadhayalan, N.; Lin, K.C.; Saleh, T.A. Recent advances in functionalized carbon dots toward the design of efficient materials for sensing and catalysis applications. Small 2020, 16, 1905767. [Google Scholar] [CrossRef] [PubMed]
  13. Hua, X.W.; Bao, Y.W.; Chen, Z.; Wu, F.G. Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics. Nanoscale 2017, 9, 10948–10960. [Google Scholar] [CrossRef] [PubMed]
  14. Li, M.; Chen, T.; Gooding, J.J.; Liu, J. Review of carbon and graphene quantum dots for sensing. ACS Sens. 2019, 4, 1732–1748. [Google Scholar] [CrossRef] [PubMed]
  15. Lin, F.; Jia, C.; Wu, F.G. Carbon dots for intracellular sensing. Small Struct. 2022, 3, 2200033. [Google Scholar] [CrossRef]
  16. Lin, F.; Bao, Y.W.; Wu, F.G. Carbon dots for sensing and killing microorganisms. C 2019, 5, 33. [Google Scholar] [CrossRef] [Green Version]
  17. Feng, T.; Tao, S.; Yue, D.; Zeng, Q.; Chen, W.; Yang, B. Recent advances in energy conversion applications of carbon dots: From optoelectronic devices to electrocatalysis. Small 2020, 16, 2001295. [Google Scholar] [CrossRef]
  18. Hu, C.; Li, M.; Qiu, J.; Sun, Y.P. Design and fabrication of carbon dots for energy conversion and storage. Chem. Soc. Rev. 2019, 48, 2315–2337. [Google Scholar] [CrossRef]
  19. Hutton, G.A.M.; Martindale, B.C.M.; Reisner, E. Carbon dots as photosensitisers for solar-driven catalysis. Chem. Soc. Rev. 2017, 46, 6111–6123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Hassan, M.; Gomes, V.G.; Dehghani, A.; Ardekani, S.M. Engineering carbon quantum dots for photomediated theranostics. Nano Res. 2018, 11, 1–41. [Google Scholar] [CrossRef]
  21. Yang, J.; Zhang, X.; Ma, Y.H.; Gao, G.; Chen, X.; Jia, H.R.; Li, Y.H.; Chen, Z.; Wu, F.G. Carbon dot-based platform for simultaneous bacterial distinguishment and antibacterial applications. ACS Appl. Mater. Interfaces 2016, 8, 32170–32181. [Google Scholar] [CrossRef]
  22. Ran, H.H.; Cheng, X.; Bao, Y.W.; Hua, X.W.; Gao, G.; Zhang, X.; Jiang, Y.W.; Zhu, Y.X.; Wu, F.G. Multifunctional quaternized carbon dots with enhanced biofilm penetration and eradication efficiencies. J. Mater. Chem. B 2019, 7, 5104–5114. [Google Scholar] [CrossRef]
  23. Li, P.; Sun, L.; Xue, S.; Qu, D.; An, L.; Wang, X.; Sun, Z. Recent advances of carbon dots as new antimicrobial agents. SmartMat 2022, 3, 226–248. [Google Scholar] [CrossRef]
  24. Wang, Z.X.; Wang, Z.; Wu, F.G. Carbon dots as drug delivery vehicles for antimicrobial applications: A minireview. ChemMedChem 2022, 17, e202200003. [Google Scholar] [CrossRef]
  25. Xu, X.; Ray, R.; Gu, Y.; Ploehn, H.J.; Gearheart, L.; Raker, K.; Scrivens, W.A. Electrophoretic analysis and purification of fluorescent single-walled carbon nanotube fragments. J. Am. Chem. Soc. 2004, 126, 12736–12737. [Google Scholar] [CrossRef]
  26. Alavi, M.; Jabari, E.; Jabbari, E. Functionalized carbon-based nanomaterials and quantum dots with antibacterial activity: A review. Expert Rev. Anti. Infect. Ther. 2021, 19, 35–44. [Google Scholar] [CrossRef]
  27. Shahshahanipour, M.; Rezaei, B.; Ensafi, A.A.; Etemadifar, Z. An ancient plant for the synthesis of a novel carbon dot and its applications as an antibacterial agent and probe for sensing of an anti-cancer drug. Mater. Sci. Eng. C 2019, 98, 826–833. [Google Scholar] [CrossRef]
  28. Boobalan, T.; Sethupathi, M.; Sengottuvelan, N.; Kumar, P.; Balaji, P.; Gulyás, B.; Padmanabhan, P.; Selvan, S.T.; Arun, A. Mushroom-derived carbon dots for toxic metal ion detection and as antibacterial and anticancer agents. ACS Appl. Nano Mater. 2020, 3, 5910–5919. [Google Scholar] [CrossRef]
  29. Ma, Y.; Zhang, M.; Wang, H.; Wang, B.; Huang, H.; Liu, Y.; Kang, Z. N-doped carbon dots derived from leaves with low toxicity via damaging cytomembrane for broad-spectrum antibacterial activity. Mater. Today Commun. 2020, 24, 101222. [Google Scholar] [CrossRef]
  30. Surendran, P.; Lakshmanan, A.; Priya, S.S.; Geetha, P.; Rameshkumar, P.; Kannan, K.; Hegde, T.A.; Vinitha, G. Fluorescent carbon quantum dots from Ananas comosus waste peels: A promising material for NLO behaviour, antibacterial, and antioxidant activities. Inorg. Chem. Commun. 2021, 124, 108397. [Google Scholar] [CrossRef]
  31. Liu, S.; Quan, T.; Yang, L.; Deng, L.; Kang, X.; Gao, M.; Xia, Z.; Li, X.; Gao, D. N,Cl-codoped carbon dots from Impatiens balsamina L. stems and a deep eutectic solvent and their applications for Gram-positive bacteria identification, antibacterial activity, cell imaging, and ClO− sensing. ACS Omega 2021, 6, 29022–29036. [Google Scholar] [CrossRef]
  32. Genc, M.T.; Yanalak, G.; Aksoy, I.; Aslan, E.; Patır, I.H. Green carbon dots (GCDs) for photocatalytic hydrogen evolution and antibacterial applications. ChemistrySelect 2021, 6, 7317–7322. [Google Scholar] [CrossRef]
  33. Saravanan, A.; Maruthapandi, M.; Das, P.; Luong, J.H.T.; Gedanken, A. Green synthesis of multifunctional carbon dots with antibacterial activities. Nanomaterials 2021, 11, 369. [Google Scholar] [CrossRef]
  34. Eskalen, H.; Çeşme, M.; Kerli, S.; Özğan, Ş. Green synthesis of water-soluble fluorescent carbon dots from rosemary leaves: Applications in food storage capacity, fingerprint detection, and antibacterial activity. J. Chem. Res. 2021, 45, 428–435. [Google Scholar] [CrossRef]
  35. Pandiyan, S.; Arumugam, L.; Srirengan, S.P.; Pitchan, R.; Sevugan, P.; Kannan, K.; Pitchan, G.; Hegde, T.A.; Gandhirajan, V. Biocompatible carbon quantum dots derived from sugarcane industrial wastes for effective nonlinear optical behavior and antimicrobial activity applications. ACS Omega 2020, 5, 30363–30372. [Google Scholar] [CrossRef]
  36. Qing, W.; Chen, K.; Yang, Y.; Wang, Y.; Liu, X. Cu2+-doped carbon dots as fluorescence probe for specific recognition of Cr(VI) and its antimicrobial activity. Microchem. J. 2020, 152, 104262. [Google Scholar] [CrossRef]
  37. Das, P.; Maruthapandi, M.; Saravanan, A.; Natan, M.; Jacobi, G.; Banin, E.; Gedanken, A. Carbon dots for heavy-metal sensing, pH-sensitive cargo delivery, and antibacterial applications. ACS Appl. Nano Mater. 2020, 3, 11777–11790. [Google Scholar] [CrossRef]
  38. Zhao, X.; Wang, L.; Ren, S.; Hu, Z.; Wang, Y. One-pot synthesis of Forsythia@carbon quantum dots with natural anti-wood rot fungus activity. Mater. Des. 2021, 206, 109800. [Google Scholar] [CrossRef]
  39. Wang, H.; Zhang, M.; Ma, Y.; Wang, B.; Shao, M.; Huang, H.; Liu, Y.; Kang, Z. Selective inactivation of Gram-negative bacteria by carbon dots derived from natural biomass: Artemisia argyi leaves. J. Mater. Chem. B 2020, 8, 2666–2672. [Google Scholar] [CrossRef]
  40. Zhao, D.; Liu, X.; Zhang, R.; Huang, X.; Xiao, X. Facile one-pot synthesis of multifunctional protamine sulfate-derived carbon dots for antibacterial applications and fluorescence imaging of bacteria. New J. Chem. 2021, 45, 1010–1019. [Google Scholar] [CrossRef]
  41. Suner, S.S.; Sahiner, M.; Ayyala, R.S.; Bhethanabotle, V.R.; Sahiner, N. Nitrogen-doped arginine carbon dots and its metal nanoparticle composites as antibacterial agent. C 2020, 6, 58. [Google Scholar] [CrossRef]
  42. Pandey, A.; Devkota, A.; Yadegari, Z.; Dumenyo, K.; Taheri, A. Antibacterial properties of citric acid/β-alanine carbon dots against Gram-negative bacteria. Nanomaterials 2021, 11, 2012. [Google Scholar] [CrossRef] [PubMed]
  43. Kang, J.W.; Kang, D.H. Effect of amino acid-derived nitrogen and/or sulfur doping on the visible-light-driven antimicrobial activity of carbon quantum dots: A comparative study. Chem. Eng. J. 2021, 420, 129990. [Google Scholar] [CrossRef]
  44. Suner, S.S.; Sahiner, M.; Ayyala, R.S.; Bhethanabotla, V.R.; Sahiner, N. Versatile Fluorescent carbon dots from citric acid and cysteine with antimicrobial, anti-biofilm, antioxidant, and AChE enzyme inhibition capabilities. J. Fluoresc. 2021, 31, 1705–1717. [Google Scholar] [CrossRef] [PubMed]
  45. Gagic, M.; Kociova, S.; Smerkova, K.; Michalkova, H.; Setka, M.; Svec, P.; Pribyl, J.; Masilko, J.; Balkova, R.; Heger, Z.; et al. One-pot synthesis of natural amine-modified biocompatible carbon quantum dots with antibacterial activity. J. Colloid Interf. Sci. 2020, 580, 30–48. [Google Scholar] [CrossRef]
  46. Hao, X.; Huang, L.; Zhao, C.; Chen, S.; Lin, W.; Lin, Y.; Zhang, L.; Sun, A.; Miao, C.; Lin, X.; et al. Antibacterial activity of positively charged carbon quantum dots without detectable resistance for wound healing with mixed bacteria infection. Mater. Sci. Eng. C 2021, 123, 111971. [Google Scholar] [CrossRef]
  47. Geng, B.; Li, P.; Fang, F.; Shi, W.; Glowacki, J.; Pan, D.; Shen, L. Antibacterial and osteogenic carbon quantum dots for regeneration of bone defects infected with multidrug-resistant bacteria. Carbon 2021, 184, 375–385. [Google Scholar] [CrossRef]
  48. Yang, J.; Gao, G.; Zhang, X.; Ma, Y.H.; Chen, X.; Wu, F.G. One-step synthesis of carbon dots with bacterial contact-enhanced fluorescence emission: Fast Gram-type identification and selective Gram-positive bacterial inactivation. Carbon 2019, 146, 827–839. [Google Scholar] [CrossRef]
  49. Wang, H.; Song, Z.; Gu, J.; Li, S.; Wu, Y.; Han, H. Nitrogen-doped carbon quantum dots for preventing biofilm formation and eradicating drug-resistant bacteria infection. ACS Biomater. Sci. Eng. 2019, 5, 4739–4749. [Google Scholar] [CrossRef]
  50. Li, P.; Yang, X.; Zhang, X.; Pan, J.; Tang, W.; Cao, W.; Zhou, J.; Gong, X.; Xing, X. Surface chemistry-dependent antibacterial and antibiofilm activities of polyamine-functionalized carbon quantum dots. J. Mater. Sci. 2020, 55, 16744–16757. [Google Scholar] [CrossRef]
  51. Zhao, D.; Zhang, Z.; Liu, X.; Zhang, R.; Xiao, X. Rapid and low-temperature synthesis of N, P co-doped yellow emitting carbon dots and their applications as antibacterial agent and detection probe to Sudan Red I. Mater. Sci. Eng. C 2021, 119, 111468. [Google Scholar] [CrossRef] [PubMed]
  52. Zhao, D.; Zhang, R.; Liu, S.; Huang, X.; Xiao, X.; Yuan, L. One-step synthesis of blue-green luminescent carbon dots by a low-temperature rapid method and their high-performance antibacterial effect and bacterial imaging. Nanotechnology 2021, 32, 155101. [Google Scholar] [CrossRef] [PubMed]
  53. Tang, W.; Li, P.; Zhang, G.; Yang, X.; Yu, M.; Lu, H.; Xing, X. Antibacterial carbon dots derived from polyethylene glycol/polyethyleneimine with potent anti-friction performance as water-based lubrication additives. J. Appl. Polym. Sci. 2021, 138, e50620. [Google Scholar] [CrossRef]
  54. Zhao, C.; Wang, X.; Wu, L.; Wu, W.; Zheng, Y.; Lin, L.; Weng, S.; Lin, X. Nitrogen-doped carbon quantum dots as an antimicrobial agent against Staphylococcus for the treatment of infected wounds. Colloids Surf. B 2019, 179, 17–27. [Google Scholar] [CrossRef] [PubMed]
  55. Anand, S.R.; Bhati, A.; Saini, D.; Gunture; Chauhan, N.; Khare, P.; Sonkar, S.K. Antibacterial nitrogen-doped carbon dots as a reversible “fluorescent nanoswitch” and fluorescent ink. ACS Omega 2019, 4, 1581–1591. [Google Scholar] [CrossRef]
  56. Ye, Z.; Li, G.; Lei, J.; Liu, M.; Jin, Y.; Li, B. One-step and one-precursor hydrothermal synthesis of carbon dots with superior antibacterial activity. ACS Appl. Bio Mater. 2020, 3, 7095–7102. [Google Scholar] [CrossRef]
  57. Saravanan, A.; Maruthapandi, M.; Das, P.; Ganguly, S.; Margel, S.; Luong, J.H.T.; Gedanken, A. Applications of N-doped carbon dots as antimicrobial agents, antibiotic carriers, and selective fluorescent probes for nitro explosives. ACS Appl. Bio Mater. 2020, 3, 8023–8031. [Google Scholar] [CrossRef]
  58. Chu, X.; Wu, F.; Sun, B.; Zhang, M.; Song, S.; Zhang, P.; Wang, Y.; Zhang, Q.; Zhou, N.; Shen, J. Genipin cross-linked carbon dots for antimicrobial, bioimaging and bacterial discrimination. Colloids Surf. B 2020, 190, 110930. [Google Scholar] [CrossRef]
  59. Li, P.; Yu, M.; Ke, X.; Gong, X.; Li, Z.; Xing, X. Cytocompatible amphipathic carbon quantum dots as potent membrane-active antibacterial agents with low drug resistance and effective inhibition of biofilm formation. ACS Appl. Bio Mater. 2022, 5, 3290–3299. [Google Scholar] [CrossRef]
  60. Zhao, D.; Liu, X.; Zhang, R.; Xiao, X.; Li, J. Preparation of two types of silver-doped fluorescent carbon dots and determination of their antibacterial properties. J. Inorg. Biochem. 2021, 214, 111306. [Google Scholar] [CrossRef]
  61. Liu, Y.; Xu, B.; Lu, M.; Li, S.; Guo, J.; Chen, F.; Xiong, X.; Yin, Z.; Liu, H.; Zhou, D. Ultrasmall Fe-doped carbon dots nanozymes for photoenhanced antibacterial therapy and wound healing. Bioact. Mater. 2022, 12, 246–256. [Google Scholar] [CrossRef] [PubMed]
  62. Liu, M.; Huang, L.; Xu, X.; Wei, X.; Yang, X.; Li, X.; Wang, B.; Xu, Y.; Li, L.; Yang, Z. Copper doped carbon dots for addressing bacterial biofilm formation, wound infection, and tooth staining. ACS Nano 2022, 16, 9479–9497. [Google Scholar] [CrossRef] [PubMed]
  63. Xu, Z.; He, H.; Zhang, S.; Wang, B.; Jin, J.; Li, C.; Chen, X.; Jiang, B.; Liu, Y. Mechanistic studies on the antibacterial behavior of Ag nanoparticles decorated with carbon dots having different oxidation degrees. Environ. Sci. Nano 2019, 6, 1168–1179. [Google Scholar] [CrossRef]
  64. Raina, S.; Thakur, A.; Sharma, A.; Pooja, D.; Minhas, A.P. Bactericidal activity of Cannabis sativa phytochemicals from leaf extract and their derived carbon dots and Ag@carbon dots. Mater. Lett. 2020, 262, 127122. [Google Scholar] [CrossRef]
  65. Wei, X.; Cheng, F.; Yao, Y.; Yi, X.; Wei, B.; Li, H.; Wu, Y.; He, J. Facile synthesis of a carbon dots and silver nanoparticles (CDs/AgNPs) composite for antibacterial application. RSC Adv. 2021, 11, 18417–18422. [Google Scholar] [CrossRef]
  66. Moradlou, O.; Rabiei, Z.; Delavari, N. Antibacterial effects of carbon quantum dots@hematite nanostructures deposited on titanium against Gram-positive and Gram-negative bacteria. J. Potoch. Photobio. A 2019, 379, 144–149. [Google Scholar] [CrossRef] [Green Version]
  67. Abd Elkodous, M.; EI-Sayyad, G.S.; Youssry, S.M.; Nada, H.G.; Gobara, M.; Elsayed, M.A.; EI-Khawaga, A.M.; Kawamura, G.; Tan, W.K.; EI-Batal, A.I.; et al. Carbon-dot-loaded CoxNi1−xFe2O4; x = 0.9/SiO2/TiO2 nanocomposite with enhanced photocatalytic and antimicrobial potential: An engineered nanocomposite for wastewater treatment. Sci. Rep. 2020, 10, 11534. [Google Scholar] [CrossRef]
  68. Gao, X.; Ma, X.; Han, X.; Wang, X.; Li, S.; Yao, J.; Shi, W. Synthesis of carbon dot-ZnO-based nanomaterials for antibacterial application. New J. Chem. 2021, 45, 4496–4505. [Google Scholar] [CrossRef]
  69. Chen, Y.; Cheng, X.; Wang, W.; Jin, Z.; Liu, Q.; Yang, H.; Cao, Y.; Li, W.; Fakhri, A.; Gupta, V.K. Preparation of carbon dots-hematite quantum dots-loaded hydroxypropyl cellulose-chitosan nanocomposites for drug delivery, sunlight catalytic and antimicrobial application. J. Potoch. Photobio. B 2021, 219, 112201. [Google Scholar] [CrossRef] [PubMed]
  70. Nemera, D.J.; Etefa, H.F.; Kumar, V.; Dejene, F.B. Hybridization of nickel oxide nanoparticles with carbon dots and its application for antibacterial activities. Luminescence 2022, 37, 965–970. [Google Scholar] [CrossRef] [PubMed]
  71. Gao, X.; Li, H.; Niu, X.; Zhang, D.; Wang, Y.; Fan, H.; Wang, K. Carbon quantum dots modified Ag2S/CS nanocomposite as effective antibacterial agents. J. Inorg. Biochem. 2021, 220, 111456. [Google Scholar] [CrossRef] [PubMed]
  72. Luo, Q.; Qin, K.; Liu, F.; Zheng, X.; Ding, Y.; Zhang, C.; Xu, M.; Liu, X.; Wei, Y. Carbon dots derived from kanamycin sulfate with antibacterial activity and selectivity for Cr6+ detection. Analyst 2021, 146, 1965–1972. [Google Scholar] [CrossRef] [PubMed]
  73. Liang, J.; Li, W.; Chen, J.; Huang, X.; Liu, Y.; Zhang, X.; Shu, W.; Lei, B.; Zhang, H. Antibacterial activity and synergetic mechanism of carbon dots against Gram-positive and -negative bacteria. ACS Appl. Bio Mater. 2021, 4, 6937–6945. [Google Scholar] [CrossRef]
  74. Wu, L.N.; Yang, Y.J.; Huang, L.X.; Zhong, Y.; Chen, Y.; Gao, Y.R.; Lin, L.Q.; Lei, Y.; Liu, A.L. Levofloxacin-based carbon dots to enhance antibacterial activities and combat antibiotic resistance. Carbon 2022, 186, 452–464. [Google Scholar] [CrossRef]
  75. Zhao, C.; Wu, L.; Wang, X.; Weng, S.; Ruan, Z.; Liu, Q.; Lin, L.; Lin, X. Quaternary ammonium carbon quantum dots as an antimicrobial agent against Gram-positive bacteria for the treatment of MRSA-infected pneumonia in mice. Carbon 2020, 163, 70–84. [Google Scholar] [CrossRef]
  76. Chu, X.; Zhang, P.; Liu, Y.; Sun, B.; Huang, X.; Zhou, N.; Shen, J.; Meng, N. A multifunctional carbon dot-based nanoplatform for bioimaging and quaternary ammonium salt/photothermal synergistic antibacterial therapy. J. Mater. Chem. B 2022, 10, 2865–2874. [Google Scholar] [CrossRef] [PubMed]
  77. Liu, W.; Gu, H.; Ran, B.; Liu, W.; Sun, W.; Wang, D.; Du, J.; Fan, J.; Peng, X. Accelerated antibacterial red-carbon dots with photodynamic therapy against multidrug-resistant Acinetobacter baumannii. Sci. China Mater. 2022, 65, 845–854. [Google Scholar] [CrossRef] [PubMed]
  78. Li, C.; Lin, F.; Sun, W.; Wu, F.G.; Yang, H.; Lv, R.; Zhu, Y.X.; Jia, H.R.; Wang, C.; Gao, G.; et al. Self-assembled rose bengal-exopolysaccharide nanoparticles for improved photodynamic inactivation of bacteria by enhancing singlet oxygen generation directly in the solution. ACS Appl. Mater. Interfaces 2018, 10, 16715–16722. [Google Scholar] [CrossRef] [PubMed]
  79. Lin, F.; Bao, Y.W.; Wu, F.G. Improving the phototherapeutic efficiencies of molecular and nanoscale materials by targeting mitochondria. Molecules 2018, 23, 3016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  80. LeCroy, G.E.; Yang, S.T.; Yang, F.; Liu, Y.; Shiral Fernando, K.A.; Bunker, C.E.; Hu, Y.; Luo, P.G.; Sun, Y.P. Functionalized carbon nanoparticles: Syntheses and applications in optical bioimaging and energy conversion. Coord. Chem. Rev. 2016, 320–321, 66–81. [Google Scholar] [CrossRef]
  81. Venkateswarlu, S.; Viswanath, B.; Reddy, A.S.; Yoon, M. Fungus-derived photoluminescent carbon nanodots for ultrasensitive detection of Hg2+ ions and photoinduced bactericidal activity. Sens. Actuators B Chem. 2018, 258, 172–183. [Google Scholar] [CrossRef]
  82. Ristic, B.Z.; Milenkovic, M.M.; Dakic, I.R.; Todorovic-Markovic, B.M.; Milosavljevic, M.S.; Budimir, M.D.; Paunovic, V.G.; Dramicanin, M.D.; Markovic, Z.M.; Trajkovic, V.S. Photodynamic antibacterial effect of graphene quantum dots. Biomaterials 2014, 35, 4428–4435. [Google Scholar] [CrossRef] [PubMed]
  83. Stanković, N.K.; Bodik, M.; Šiffalovič, P.; Kotlar, M.; Mičušik, M.; Špitalsky, Z.; Danko, M.; Milivojević, D.D.; Kleinova, A.; Kubat, P.; et al. Antibacterial and antibiofouling properties of light triggered fluorescent hydrophobic carbon quantum dots Langmuir–Blodgett thin films. ACS Sustain. Chem. Eng. 2018, 6, 4154–4163. [Google Scholar] [CrossRef]
  84. Yadav, P.; Nishanthi, S.T.; Purohit, B.; Shanavas, A.; Kailasam, K. Metal-free visible light photocatalytic carbon nitride quantum dots as efficient antibacterial agents: An insight study. Carbon 2019, 152, 587–597. [Google Scholar] [CrossRef]
  85. Nie, X.; Jiang, C.; Wu, S.; Chen, W.; Lv, P.; Wang, Q.; Liu, J.; Narh, C.; Cao, X.; Ghiladi, R.A.; et al. Carbon quantum dots: A bright future as photosensitizers for in vitro antibacterial photodynamic inactivation. J. Potoch. Photobio. B 2020, 206, 111864. [Google Scholar] [CrossRef]
  86. Wang, X.; Lu, Y.; Hua, K.; Yang, D.; Yang, Y. Iodine-doped carbon dots with inherent peroxidase catalytic activity for photocatalytic antibacterial and wound disinfection. Anal. Bioanal. Chem. 2021, 413, 1373–1382. [Google Scholar] [CrossRef] [PubMed]
  87. Liu, D.; Yang, M.; Liu, X.; Yu, W. Zinc-doped carbon dots as effective blue-light-activated antibacterial agent. Nano 2021, 16, 2150031. [Google Scholar] [CrossRef]
  88. Nichols, F.; Lu, J.E.; Mecado, R.; Rojas-Andrade, M.D.; Ning, S.; Azhar, Z.; Sandhu, J.; Cazares, R.; Saltikov, C.; Chen, S. Antibacterial activity of nitrogen-doped carbon dots enhanced by atomic aispersion of copper. Langmuir 2020, 36, 11629–11636. [Google Scholar] [CrossRef]
  89. Li, H.; Tian, H.; Yu, L.; Gao, Z.; Yang, Y.; Li, W. Preparation of terbium doped carbon dots and their antibacterial capacity against Escherichia coli. Acta Agric. Zhejiangensis 2020, 32, 291–298. [Google Scholar]
  90. Yan, H.; Zhang, B.; Zhang, Y.; Su, R.; Li, P.; Su, W. Fluorescent carbon dot-curcumin nanocomposites for remarkable antibacterial activity with synergistic photodynamic and photothermal abilities. ACS Appl. Bio Mater. 2021, 4, 6703–6718. [Google Scholar] [CrossRef] [PubMed]
  91. Zhang, P.; Sun, B.; Wu, F.; Zhang, Q.; Chu, X.; Ge, M.; Zhou, N.; Shen, J. Wound healing acceleration by antibacterial biodegradable black phosphorus nanosheets loaded with cationic carbon dots. J. Mater. Sci. 2021, 56, 6411–6426. [Google Scholar] [CrossRef]
  92. Yan, Y.; Kuang, W.; Shi, L.; Ye, X.; Yang, Y.; Xie, X.; Shi, Q.; Tan, S. Carbon quantum dot-decorated TiO2 for fast and sustainable antibacterial properties under visible-light. J. Alloys Compd. 2019, 777, 234–243. [Google Scholar] [CrossRef]
  93. Jin, C.; Su, K.; Tan, L.; Liu, X.; Cui, Z.; Yang, X.; Li, Z.; Liang, Y.; Zhu, S.; Yeung, K.W.K. Near-infrared light photocatalysis and photothermy of carbon quantum dots and Au nanoparticles loaded titania nanotube array. Mater. Des. 2019, 177, 107845. [Google Scholar] [CrossRef]
  94. Kuang, W.; Zhong, Q.; Ye, X.; Yan, Y.; Yang, Y.; Zhang, J.; Huang, L.; Tan, S.; Shi, Q. Antibacterial nanorods made of carbon quantum dots-ZnO under visible light irradiation. J. Nanosci. Nanotechno. 2019, 19, 3982–3990. [Google Scholar] [CrossRef]
  95. Gao, D.; Zhao, P.; Lyu, B.; Li, Y.; Hou, Y.; Ma, J. Carbon quantum dots decorated on ZnO nanoparticles: An efficient visible-light responsive antibacterial agents. Appl. Organomet. Chem. 2020, 34, e5665. [Google Scholar] [CrossRef]
  96. Marković, Z.M.; Kováčová, M.; Humpolíček, P.; Budimir, M.D.; Vajd’ák, J.; Kubát, P.; Mičušík, M.; Švajdlenková, H.; Danko, M.; Capáková, Z.; et al. Antibacterial photodynamic activity of carbon quantum dots/polydimethylsiloxane nanocomposites against Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae. Photodiagnosis Photodyn. Ther. 2019, 26, 342–349. [Google Scholar] [CrossRef]
  97. Kováčová, M.; Bodík, M.; Mičušík, M.; Humpolíček, P.; Šiffalovič, P.; Špitalský, Z. Increasing the effectivity of the antimicrobial surface of carbon quantum dots-based nanocomposite by atmospheric pressure plasma. Clin. Plasma Med. 2020, 19–20, 100111. [Google Scholar] [CrossRef]
  98. Ghosal, K.; Kováčová, M.; Humpolíček, P.; Vajd’ák, J.; Bodík, M.; Špitalský, Z. Antibacterial photodynamic activity of hydrophobic carbon quantum dots and polycaprolactone based nanocomposite processed via both electrospinning and solvent casting method. Photodiagnosis Photodyn. Ther. 2021, 35, 102455. [Google Scholar] [CrossRef]
  99. Budimir, M.; Marković, Z.; Vajdak, J.; Jovanović, S.; Kubat, P.; Humpoliček, P.; Mičušik, M.; Danko, M.; Barras, A.; Milivojevič, D.; et al. Enhanced visible light-triggered antibacterial activity of carbon quantum dots/polyurethane nanocomposites by gamma rays induced pre-treatment. Radiat. Phys. Chem. 2021, 185, 109499. [Google Scholar] [CrossRef]
  100. Belkahla, H.; Boudjemaa, R.; Caosi, V.; Pineau, D.; Curcio, A.; Lomas, J.S.; Decorse, P.; Chevillot-Biraud, A.; Azaïs, T.; Wilhelm, C.; et al. Carbon dots, a powerful non-toxic support for bioimaging by fluorescence nanoscopy and eradication of bacteria by photothermia. Nanoscale Adv. 2019, 1, 2571. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Yan, H.; Ni, H.; Yang, Y.; Shan, C.; Yang, X.; Li, X.; Cao, J.; Wu, W.; Liu, W.; Tang, Y. Smart nanoprobe based on two-photon sensitized terbium-carbon dots for dual-mode fluorescence thermometer and antibacterial. Chin. Chem. Lett. 2020, 31, 1792–1796. [Google Scholar] [CrossRef]
  102. Yan, X.; Yang, J.; Wu, J.; Su, H.; Sun, G.; Ni, Y.; Sun, W. Antibacterial carbon dots/iron oxychloride nanoplatform for chemodynamic and photothermal therapy. Colloids Interface Sci. Commun. 2021, 45, 100552. [Google Scholar] [CrossRef]
  103. Mazumdar, A.; Haddad, Y.; Milosavljevic, V.; Michalkova, H. Guran, R.; Bhowmick, S.; Moulick, A. Peptide-carbon quantum dots conjugate, derived from human retinoic acid receptor responder protein 2, against antibiotic-resistant Gram positive and Gram negative pathogenic bacteria. Nanomaterials 2020, 10, 325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Liu, S.; Lv, K.; Chen, Z.; Li, C.; Chen, T.; Ma, D. Fluorescent carbon dots with a high nitric oxide payload for effective antibacterial activity and bacterial imaging. Biomater. Sci. 2021, 9, 6486–6500. [Google Scholar] [CrossRef] [PubMed]
  105. Mahat, N.A.; Shamsudin, S.A.; Jullok, N.; Ma’Radzi, A.H. Carbon quantum dots embedded polysulfone membranes for antibacterial performance in the process of forward osmosis. Desalination 2020, 493, 114618. [Google Scholar] [CrossRef]
  106. Koulivand, H.; Shahbazi, A.; Vatanpour, V.; Rahmandoost, M. Novel antifouling and antibacterial polyethersulfone membrane prepared by embedding nitrogen-doped carbon dots for efficient salt and dye rejection. Mater. Sci. Eng. C 2020, 111, 110787. [Google Scholar] [CrossRef]
  107. Kousheh, S.A.; Moradi, M.; Tajik, H.; Molaei, R. Preparation of antimicrobial/ultraviolet protective bacterial nanocellulose film with carbon dots synthesized from lactic acid bacteria. Int. J. Biol. Macromol. 2020, 155, 216–225. [Google Scholar]
  108. Riahi, Z.; Rhim, J.W.; Bagheri, R.; Pircheraghi, G.; Lotfali, E. Carboxymethyl cellulose-based functional film integrated with chitosan-based carbon quantum dots for active food packaging applications. Prog. Org. Coat. 2022, 166, 106794. [Google Scholar] [CrossRef]
Pharmaceuticals 15 01236 sch001 550
Scheme 1. Scheme illustrating the different types of antimicrobial CDs for biomedical and industrial applications.
Scheme 1. Scheme illustrating the different types of antimicrobial CDs for biomedical and industrial applications.
Pharmaceuticals 15 01236 sch001
Pharmaceuticals 15 01236 g001 550
Figure 1. Biomass-derived nitrogen-doped antimicrobial CDs. (A) Scheme depicting the synthesis of ACDs. (B) Left: Transmission electron microscopy (TEM) image and high-resolution TEM image (inset) of ACDs. Right: corresponding size distribution. (C) Effect of 150 μg mL−1 ACDs on the growth of E. coli, kanamycin-resistant E. coli (KRE. coli), ampicillin-resistant E. coli (ARE. coli), P. aeruginosa, P. vulgaris, S. aureus, and B. subtilis. (D) Scanning electron microscopy (SEM) images of E. coli incubated without ACDs (a and b) and with ACDs (c and d), and S. aureus incubated without ACDs (e and f) and with ACDs (g and h). ACDs could only disrupt the cell walls of E. coli rather than those of S. aureus. (A–D) Reproduced with permission from [39]. Copyright 2020, The Royal Society of Chemistry.
Figure 1. Biomass-derived nitrogen-doped antimicrobial CDs. (A) Scheme depicting the synthesis of ACDs. (B) Left: Transmission electron microscopy (TEM) image and high-resolution TEM image (inset) of ACDs. Right: corresponding size distribution. (C) Effect of 150 μg mL−1 ACDs on the growth of E. coli, kanamycin-resistant E. coli (KRE. coli), ampicillin-resistant E. coli (ARE. coli), P. aeruginosa, P. vulgaris, S. aureus, and B. subtilis. (D) Scanning electron microscopy (SEM) images of E. coli incubated without ACDs (a and b) and with ACDs (c and d), and S. aureus incubated without ACDs (e and f) and with ACDs (g and h). ACDs could only disrupt the cell walls of E. coli rather than those of S. aureus. (A–D) Reproduced with permission from [39]. Copyright 2020, The Royal Society of Chemistry.
Pharmaceuticals 15 01236 g001
Pharmaceuticals 15 01236 g002 550
Figure 2. Schematic diagram showing the preparation of nitrogen-doped CDs with antimicrobial activities from (A) protamine sulfate (PS), (B) arginine, (C) L-glutathione, and (D) Si-QAC. (A) Reproduced with permission from [40]. Copyright 2021, The Royal Society of Chemistry. (B) Reproduced with permission from [41]. Copyright 2020, MDPI. (C) Reproduced with permission from [46]. Copyright 2021, Elsevier B.V. (D) Reproduced with permission from [48]. Copyright 2019, Elsevier Ltd.
Figure 2. Schematic diagram showing the preparation of nitrogen-doped CDs with antimicrobial activities from (A) protamine sulfate (PS), (B) arginine, (C) L-glutathione, and (D) Si-QAC. (A) Reproduced with permission from [40]. Copyright 2021, The Royal Society of Chemistry. (B) Reproduced with permission from [41]. Copyright 2020, MDPI. (C) Reproduced with permission from [46]. Copyright 2021, Elsevier B.V. (D) Reproduced with permission from [48]. Copyright 2019, Elsevier Ltd.
Pharmaceuticals 15 01236 g002
Pharmaceuticals 15 01236 g003 550
Figure 3. Metal-containing CDs for killing microorganims. (A) Scheme depicting the synthesis of CD-1 and CD-2, and their antibacterial properties. Reproduced with permission from [60]. Copyright 2021, Elsevier Inc. (B) Antibacterial mechanism of CD/ZnO/ZnAl2O4. Reproduced with permission from [68]. Copyright 2021, The Royal Society of Chemistry. (C) Scheme illustrating the formation of CQDs/Ag2S/CS and its antibacterial effect. Reproduced with permission from [71]. Copyright 2021, Elsevier Inc.
Figure 3. Metal-containing CDs for killing microorganims. (A) Scheme depicting the synthesis of CD-1 and CD-2, and their antibacterial properties. Reproduced with permission from [60]. Copyright 2021, Elsevier Inc. (B) Antibacterial mechanism of CD/ZnO/ZnAl2O4. Reproduced with permission from [68]. Copyright 2021, The Royal Society of Chemistry. (C) Scheme illustrating the formation of CQDs/Ag2S/CS and its antibacterial effect. Reproduced with permission from [71]. Copyright 2021, Elsevier Inc.
Pharmaceuticals 15 01236 g003
Pharmaceuticals 15 01236 g004 550
Figure 4. Antibacterial compound-derived CDs for killing microorganisms. (A) Construction and antibacterial characteristics of LCDs. Reproduced with permission from [74]. Copyright 2022 Elsevier Ltd. (B) Preparation of QCQDs from two quaternary ammonium compounds and their bactericidal properties and antibacterial mechanism. Reproduced with permission from [75]. Copyright 2020, Elsevier Ltd. (C) Scheme showing the preparation of N@CDs for delivering the traditional antibiotic ciprofloxacin to kill bacteria. Reproduced with permission from [57]. Copyright 2020, American Chemical Society.
Figure 4. Antibacterial compound-derived CDs for killing microorganisms. (A) Construction and antibacterial characteristics of LCDs. Reproduced with permission from [74]. Copyright 2022 Elsevier Ltd. (B) Preparation of QCQDs from two quaternary ammonium compounds and their bactericidal properties and antibacterial mechanism. Reproduced with permission from [75]. Copyright 2020, Elsevier Ltd. (C) Scheme showing the preparation of N@CDs for delivering the traditional antibiotic ciprofloxacin to kill bacteria. Reproduced with permission from [57]. Copyright 2020, American Chemical Society.
Pharmaceuticals 15 01236 g004
Pharmaceuticals 15 01236 g005 550
Figure 5. (A) Schematic diagram illustrating the preparation of BPs@CDs for eliminating bacteria. Reproduced with permission from [91]. Copyright 2021, Springer Nature. (B) Scheme illustrating the preparation of the CDs/Cur nanocomposite and its PDT- and PTT-mediated antimicrobial performance. Reproduced with permission from [90]. Copyright 2021, American Chemical Society.
Figure 5. (A) Schematic diagram illustrating the preparation of BPs@CDs for eliminating bacteria. Reproduced with permission from [91]. Copyright 2021, Springer Nature. (B) Scheme illustrating the preparation of the CDs/Cur nanocomposite and its PDT- and PTT-mediated antimicrobial performance. Reproduced with permission from [90]. Copyright 2021, American Chemical Society.
Pharmaceuticals 15 01236 g005
Pharmaceuticals 15 01236 g006 550
Figure 6. (A) Schematic representation of the synthesis of a p-CQD/WS2/n-CQD/GelMA hydrogel for regeneration of bone defects. Micro computed tomography (micro-CT) images of calvarial defects treated with GelMA and p-CQD/WS2/n-CQD/GelMA hydrogels for 0 or 60 days were presented. Reproduced with permission from [47]. Copyright 2021, Elsevier Ltd. (B) Scheme showing the fabrication of a CQDs-coated PSF membrane for realizing the antibacterial action in the process of forward osmosis. Reproduced with permission from [105]. Copyright 2020, Elsevier B.V.
Figure 6. (A) Schematic representation of the synthesis of a p-CQD/WS2/n-CQD/GelMA hydrogel for regeneration of bone defects. Micro computed tomography (micro-CT) images of calvarial defects treated with GelMA and p-CQD/WS2/n-CQD/GelMA hydrogels for 0 or 60 days were presented. Reproduced with permission from [47]. Copyright 2021, Elsevier Ltd. (B) Scheme showing the fabrication of a CQDs-coated PSF membrane for realizing the antibacterial action in the process of forward osmosis. Reproduced with permission from [105]. Copyright 2020, Elsevier B.V.
Pharmaceuticals 15 01236 g006
Table
Table 1. Nitrogen-doped CDs derived from biomass for killing microorganisms.
Table 1. Nitrogen-doped CDs derived from biomass for killing microorganisms.
Raw Materials Preparation MethodSize * (nm)Charge (mV)QY (%)Ref.
Lawsonia inermis (Henna)Hydrothermal treatment3–7−39 28.7[27]
Oyster mushroomHydrothermal treatment8––[28]
Osmanthus leavesHydrothermal treatment4–9−20–[29]
Tea leavesHydrothermal treatment3–7−20–[29]
Ananas comosus waste peelsHydrothermal treatment2.4 ± 0.5–10.65[30]
Impatiens balsamina L. stemsHydrothermal treatment2–4.522.4754[31]
Aloe vera leavesHydrothermal treatment10–20––[32]
Medicinal turmeric leavesHydrothermal treatment1.5–4.0−7–[33]
Rosemary leavesHydrothermal treatment16.1 ± 4.6––[34]
Sugarcane bagasse pulpHydrothermal treatment1.7 ± 0.2–17.98[35]
Waste tea extractHydrothermal treatment0.85–3.26[36]
Waste jute caddies Hydrothermal treatment6.05–14.5[37]
ForsythiaMicrowave treatment2.6––[38]
Artemisia argyi leaves Smoking simulation method2–5––[39]
* Size means the diameter distribution (or average diameter) of CDs which was determined from the corresponding TEM result.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lin, F.; Wang, Z.; Wu, F.-G. Carbon Dots for Killing Microorganisms: An Update since 2019. Pharmaceuticals 2022, 15, 1236. https://doi.org/10.3390/ph15101236

AMA Style

Lin F, Wang Z, Wu F-G. Carbon Dots for Killing Microorganisms: An Update since 2019. Pharmaceuticals. 2022; 15(10):1236. https://doi.org/10.3390/ph15101236

Chicago/Turabian Style

Lin, Fengming, Zihao Wang, and Fu-Gen Wu. 2022. "Carbon Dots for Killing Microorganisms: An Update since 2019" Pharmaceuticals 15, no. 10: 1236. https://doi.org/10.3390/ph15101236

APA Style

Lin, F., Wang, Z., & Wu, F. -G. (2022). Carbon Dots for Killing Microorganisms: An Update since 2019. Pharmaceuticals, 15(10), 1236. https://doi.org/10.3390/ph15101236

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop